Synchron is a company pioneering in neurotechnology, focusing on developing a brain-computer interface (BCI) designed to enable individuals to control digital devices using their thoughts. The company's BCI technology employs a minimally-invasive endovascular procedure to connect users with digital platforms without the need for open brain surgery. This approach is aimed at empowering autonomy and social connection by overcoming the physical limitations of the human body. Synchron is involved in clinical trials and research, working towards innovative solutions in the field of neurotechnology.